Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Overexpression of Golgi Phosphoprotein 2 Is Associated With Poor Prognosis in Oral Squamous Cell Carcinoma

Overexpression of Golgi Phosphoprotein 2 Is Associated With Poor Prognosis in Oral Squamous Cell... ObjectivesThe aims of this study were to investigate the relationship between Golgi phosphoprotein 2 (GOLPH2) and oral squamous cell carcinoma (OSCC) and explore the clinical significance of GOLPH2 in OSCC.MethodsTissue microarrays from human OSCC samples were stained for GOLPH2 expression and clinicopathologic features. Kaplan-Meier analysis was used to compare the survival of patients with high GOLPH2 expression and patients with low GOLPH2 expression.ResultsWe found GOLPH2 is highly expressed in OSCC tissue, and the GOLPH2 expression in metastatic lymph nodes is higher than in tumor tissue. Our data indicate that patients with higher GOLPH2 expression have poor overall survival compared with those with lower GOLPH2 expression. This study demonstrated that GOLPH2 was associated with CD44, SOX2, Slug, B7-H3, B7-H4, TIM3, and VISTA.ConclusionsThese findings suggest GOLPH2 is a potential marker for estimating the patient’s prognosis and may be a target for molecular-targeted therapy against OSCC. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Clinical Pathology Oxford University Press

Overexpression of Golgi Phosphoprotein 2 Is Associated With Poor Prognosis in Oral Squamous Cell Carcinoma

Download PDF
10 pages

Loading next page...
 
/lp/ou_press/overexpression-of-golgi-phosphoprotein-2-is-associated-with-poor-RBq0xO4BY2
Publisher
Oxford University Press
Copyright
© American Society for Clinical Pathology, 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
ISSN
0002-9173
eISSN
1943-7722
DOI
10.1093/ajcp/aqy029
Publisher site
See Article on Publisher Site

Abstract

ObjectivesThe aims of this study were to investigate the relationship between Golgi phosphoprotein 2 (GOLPH2) and oral squamous cell carcinoma (OSCC) and explore the clinical significance of GOLPH2 in OSCC.MethodsTissue microarrays from human OSCC samples were stained for GOLPH2 expression and clinicopathologic features. Kaplan-Meier analysis was used to compare the survival of patients with high GOLPH2 expression and patients with low GOLPH2 expression.ResultsWe found GOLPH2 is highly expressed in OSCC tissue, and the GOLPH2 expression in metastatic lymph nodes is higher than in tumor tissue. Our data indicate that patients with higher GOLPH2 expression have poor overall survival compared with those with lower GOLPH2 expression. This study demonstrated that GOLPH2 was associated with CD44, SOX2, Slug, B7-H3, B7-H4, TIM3, and VISTA.ConclusionsThese findings suggest GOLPH2 is a potential marker for estimating the patient’s prognosis and may be a target for molecular-targeted therapy against OSCC.

Journal

American Journal of Clinical Pathology – Oxford University Press

Published: May 31, 2018

References

  • Genetic etiology of oral cancer
    Ali
  • Global cancer statistics, 2012
    Torre
  • Temporal trends in the incidence and survival of cancers of the upper aerodigestive tract in Ontario and the United States
    Gupta
  • Treatment effects in patients with squamous cell carcinoma of the oral cavity
    Inagi
  • Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas
    Shingaki
  • GP73, a novel Golgi-localized protein upregulated by viral infection
    Kladney
  • Organization of the synthesis of glycolipid oligosaccharides in the Golgi complex
    Maccioni
  • N-glycosylation of the I-like domain of beta1 integrin is essential for beta1 integrin expression and biological function: identification of the minimal N-glycosylation requirement for alpha5beta1
    Isaji
  • Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas
    Riener
  • GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
    Kristiansen
  • Expression of GOLPH2 is associated with the progression of and poor prognosis in gastric cancer
    Liu
  • Golgi-related proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in cutaneous melanoma: patterns of expression and prognostic significance
    Donizy
  • GOLPH2 expression in renal cell cancer
    Fritzsche
  • Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion
    Byrne
  • Association of GOLPH2 expression with survival in non-small-cell lung cancer: clinical implications and biological validation
    Zhang
  • Golgi phosphoprotein 2 is a novel regulator of IL-12 production and macrophage polarization
    Zhang
  • The epithelial-mesenchymal transition generates cells with properties of stem cells
    Mani
  • Heterogeneity in cancer: cancer stem cells versus clonal evolution
    Shackleton
  • Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
    Visvader
  • EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
    Singh
  • CD44 as a stem cell marker in head and neck squamous cell carcinoma
    Faber
  • Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis
    Huang
  • Slug is a key mediator of hypoxia induced cadherin switch in HNSCC: correlations with poor prognosis
    Zhang
  • Immunology and immunotherapy of head and neck cancer
    Ferris
  • Molecular and cellular insights into T cell exhaustion
    Wherry
  • Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma
    Mao
  • Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma
    Wu
  • B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma
    Wu
  • T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer
    Liu